Tag: ulcerative colitis
How Air and Water Pollution Might Be Worsening Your IBD
New research reveals how air and water pollution may be contributing to IBD symptoms and inflammation. For those of us already managing Crohn’s disease or ulcerative colitis, understanding these environmental connections could be key to better health outcomes.
When Food Becomes the Enemy: Diet’s Hidden Role in IBD Flares
New research confirms what many with IBD have suspected: ultra-processed foods and inflammatory diets can worsen symptoms, while anti-inflammatory approaches like the Mediterranean diet may help. Here’s what this means for your daily food choices and IBD management.
Why Women with IBD Need Their Own Healthcare Champions
Women with IBD face unique challenges that deserve specialized medical attention and support. A new conference at Cedars-Sinai highlights the growing recognition that gender-specific IBD care is essential for optimal outcomes.
Could Breastmilk Hold the Key to Gentler IBD Treatment?
New research explores how antibodies found in breastmilk could lead to gentler IBD treatments that work with the body’s natural healing mechanisms. This approach could offer hope for managing inflammation without the harsh side effects of current therapies.
$420M Partnership Brings New Hope for Better IBD Treatments
A new $420 million partnership between Genentech and OMass Therapeutics is developing innovative oral IBD treatments using groundbreaking protein research technology. This collaboration represents significant hope for better treatment options that could transform daily life for millions living with Crohn’s disease and ulcerative colitis.
Medicare & Entyvio: Your 2025 Coverage Guide for IBD Treatment
Understanding Medicare coverage for Entyvio can feel overwhelming, but knowing your options is crucial for maintaining access to this important IBD treatment. Here’s what you need to know before 2025, including how Part B and Part D coverage work and assistance programs that can help.
New Hope on the Horizon: TREMFYA® Gets NICE Approval for IBD
NICE has officially recommended TREMFYA® as a treatment for both Crohn’s disease and ulcerative colitis, offering new hope for patients who haven’t found success with previous therapies. This breakthrough represents a meaningful step forward for the IBD community, with evidence showing effectiveness across different patient populations.
The Smoking Paradox: What UC Research Reveals About Future Hope
New Japanese research finally explains why smoking seems to protect against UC flares—by changing gut bacteria that fight inflammation. While smoking isn’t the answer, this discovery points toward safer treatments that could replicate these protective effects without the deadly risks.
Sara Levitt Shows Crohn’s Won’t Stop Her Miss Universe Dream
Miss Universe Canada contestant Sara Levitt is showing the world that Crohn’s disease won’t stop her from achieving her dreams. Her openness about living with IBD is creating powerful representation for our community and changing perceptions about what’s possible with chronic illness.
